
|Articles|April 26, 2004
Vigamox gets FDA approval for a supplemental list of susceptible pathogens
Fort Lauderdale-The FDA has approved a supplemental list of susceptiblepathogens to the in vitro labeling of Vigamox ophthalmic solution, AlconLaboratories announced Monday.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Pediatric and strabismus care: Evolving tools, emerging therapies
2
Transformative advances in vision research: It’s the science
3
SparingVision doses first patient in NYRVANA clinical trial of SPVN20 for retinitis pigmentosa
4
Eli Lilly to acquire Adverum Biotechnologies
5



















































.png)


